FDA Approves Injection for Children with GPA, MPA
September 28th 2019The FDA has given the green light to rituximab (Rituxan) injection for the treatment of granulomatosis with polyangiitus (GPA) and microscopic polyangiitis (MPA) in children age 2 and older in combination with glucocorticoids. The application was approved under priority review and with orphan designation.
Read More
Results from New Trial Show Vitamin D and Fish Oil Hopeful in Prevention of Cancer and CVD
September 25th 2019The vitamin D and omega-3 clinical trial (VITAL) is the largest, most recent study to test this subject matter, with nearly 26,000 United States men and women participating in the trial.
Read More